AEON Biopharma Amends Warrant Terms to Secure $6.2 Million in Proceeds

Article summary

AEON Biopharma has entered into an agreement to reduce the exercise price of its two-year milestone warrants, expecting to generate approximately $6.2 million in gross proceeds.